Description
BPC-157 at 10mg supports a full 8-week protocol at standard doses, or a longer maintenance cycle at reduced dose. At this format, it’s the logical choice for women managing ongoing conditions — chronic tendinopathy, leaky gut, inflammatory bowel conditions, persistent joint pain, or post-surgical recovery — where continuous support over 2–3 months is warranted.
Extended BPC-157 protocols show cumulative structural benefits: angiogenesis in injured tendon tissue takes 4–6 weeks to be measurable; gut epithelial regeneration is progressive. Women with chronic gut conditions (IBS, SIBO, post-antibiotic dysbiosis) typically run 8–12 week oral BPC-157 protocols with meaningful results. The 10mg vial makes this practical without mid-protocol interruption.
Female-calibrated dosing: 250–500mcg subcutaneously 5 days/week, or 250mcg orally in water 2x/day for gut-targeted use. The 10mg vial supports 20–40 injections at 250–500mcg. For systemic use at lower maintenance doses (100–200mcg), the vial extends further.
Storage: Store lyophilized powder below -20°C. After reconstitution, refrigerate at 2–8°C and use within 30 days.






Reviews
There are no reviews yet.